There is a realistic possibility of large waves of Covid-19 infection in the future in Britain and such waves might even be considered likely, epidemiologists who model the Covid-19 pandemic to inform government advice have said.
Prime minister Boris Johnson has ditched legal restrictions in England, saying that, while the pandemic was not over, Britain needs to learn to live with Covid.
The Scientific Pandemic Influenza Group on Modelling, Operational sub-group (SPI-M-O) said the emergence of new viral variants was the biggest unknown factor in the medium-to-long term, along with waning population immunity and changes in mixing patterns.
"Large future waves of infection that need active management to prevent detrimental pressure on the health and care sector are, at least, a realistic possibility (high confidence) or likely (medium confidence)," SPI-M-O said in a consensus statement published on Friday.
Google plans to change the model of internet communication,by releasing the GOOGLE WAVE.Google WAVE is planned to be released in later part of this year.
Over the past two years, the Covid pandemic has resulted in a backlog of elective care within the NHS, with record numbers of patients on waiting lists
across the UK. Despite efforts to catch up after the first wave, subsequent waves have put further strain on an already stretched NHS system.
This has had a tremendous impact on many patients waiting for routine dermatology appointments and, while every effort has been made to see patients with suspected
serious skin cancers within two weeks, this target is not always achieved.
With rising waiting times, pharmacists are increasingly the first port of call for patients suffering with a broad range of skin problems. From acne and rosacea,
eczema or psoriasis, to changing skin lesions or simple insect bites, pharmacists can give helpful advice, allowing some customers to find quick relief to their
skin complaint in mild cases, while directing others to see their GP without delay.
Below is some practical advice that pharmacists can give to their customers with commonly encountered skin complaints.
Acne
Acne is a common skin condition that not only affects teenagers but adults too. It is estimated that up to 40 per cent of women continue to suffer with acne into
their adult years. Acne has been linked to an increased incidence of depression, anxiety and even suicidal ideation.
Patients have reported feeling overlooked and often dismissed in their concerns by health care professionals.
Unfortunately, these issues have been further compounded by delays in being seen and treated due to the ongoing Covid pandemic. Pharmacists are well placed to help
acne patients choose the right skincare. This should consist of lightweight products, such as gel or milky cleansers, with moisturisers in serum, lotion or light
cream preparations. Some acne suitable products are further labelled as non-comedogenic.
Oil-based or occlusive preparations are best avoided. There are many good quality, non-comedogenic sun blocks suited
The UK's National Health Service (NHS) has partnered with P-Wave, a urinal products brand, to put cancer warnings for men on urinal mats in public places
across England, as part of its new earlier diagnosis drive.
Urinal mats in pubs, restaurants, shops, hotels and sports stadiums will begin to carry the message "Blood in your pee? Contact your GP practice", and men's toilets
in workplaces will also be targeted, the NHS said.
Health chiefs believe that this unique initiative will help men to spot the signs of cancer such as blood in pee, and catch the disease early.
"Having blood in your pee - even just once - shouldn't be ignored because it can be a sign of cancer, so it needs to be checked out by your GP team," said Professor
Peter Johnson, NHS England National Clinical Director for Cancer.
Two dozen parliamentarians from across the political spectrum have called on the prime minister to act as a wave of pharmacy closures in recent years has
threatened to spiral out of control.
A letter to the prime minister signed by 24 MPs and peers has warned that worse could be yet to come after "spiralling business costs" and "year after year of real
terms funding cuts" have led to hundreds of pharmacy closures.
New data from the PSNC shows that over 639 local pharmacies have been lost in England since 2016.
"This is the equivalent to just short of one pharmacy closure per constituency", the cross-party group warned.
The letter comes as MPs came together at a parliamentary summit to call for pharmacies to be embraced as a "game-changer" for tackling healthcare backlogs and taking
pressure off other areas of the NHS. A 'Future of Pharmacy' event was attended by 53 parliamentarians on July 5 in the Palace of Westminster.
At the event parliamentarians heard directly from frontline pharmacists and representatives of pharmacy bodies where a map of constituency-specific pharmacy numbers
was also unveiled, with details of the number of pharmacy closures in MPs' local area.
Eardoc device conforms especially to the structure of the ear. The device is placed behind the ear and sends out small vibrations, along the outer ear canal to the tympanic membrane. These vibrations produce tiny pressure waves that affect the walls of the Eustachian tubes causing relaxation of the surrounding tissue.
US President Obama & German Chancellor Angela Merkel may have made a tough start, but his imminent departure sparked a wave of nostalgia and trepidation in Berlin.
Hi-Lipo Cavi is the fast and non-surgical type of lipo-suction that is becoming very popular today. This Ultrasound Cavitation device uses 40KHz frequency sound waves that depletes stubborn fat cells under the skin.
Eardoc device conforms especially to the structure of the ear. The device is placed behind the ear and sends out small vibrations, along the outer ear canal to the tympanic membrane. These vibrations produce tiny pressure waves that affect the walls of the Eustachian tubes causing relaxation of the surrounding tissue. For More Details Visit us: http://www.eardoc.info/ear-infection-symptoms-and-treatment/
Earache - Natural Ear Infection Home Treatment & Remedies. Eardoc device conforms especially to the structure of the ear. The device is placed behind the ear and sends out small vibrations, along the outer ear canal to the tympanic membrane. These vibrations produce tiny pressure waves that affect the walls of the Eustachian tubes causing relaxation of the surrounding tissue.
Prime minister Boris Johnson has said he is cautious about rising cases of Covid in Europe, warning of gathering "storm clouds" of a new wave of coronavirus infections.
He made the statement during a visit today (November 12) to a vaccination centre at a community pharmacy in Sidcup, London while encouraging people to come forward
for Covid-19 boosters.
The UK has had much higher rates of Covid-19 than the rest of Western Europe since the summer when Johnson scrapped coronavirus restrictions in England.
However, rates in Britain are now coming down just as they are rising sharply in countries such as Germany, Austria and the Netherlands. Parts of Eastern Europe
have also seen a sharp rise in cases.
In continuation of the NHS Covid vaccine programme, Covid jabs for five and six-year olds will be available at the local vaccination centres or community pharmacies outside of school hours.
Following the recent JCVI guidance that recommended all children between 5 and 11 would benefit from a non-urgent offer of the COVID vaccine, the NHS will send
invitations to one million families with five and six-year-olds this week.
"Invitations being sent to families this week will set out how easy and convenient it is to take up the offer of a vaccine as part of the NHS COVID vaccination
programme by booking through the National Booking Service, or visiting their nearest walk-in site," NHS said.
Between April 25 and May 1, there are already more than 33,500 children aged five to 11 booked in for their dose of the life-saving vaccine, with a further 50,000 slots still available.
Dr Nikki Kanani, GP and Deputy Lead for the NHS COVID-19 vaccination programme, said: "It is great to see so many families already booked in for their children to receive their Covid vaccine this week, helping to protect themselves against potential future waves of the virus.
Prime minister Boris Johnson announced on Wednesday (January 19) that restrictions re-imposed in England last month would be lifted by from next Thursday (January 27).
In the latest development, the government has decided to end the guidance on working from home, asking employers to make adequate arrangements to return safely to work.
From the start of next Thursday, mandatory certification based on vaccines and tests will end, however, organisations can still choose to use the NHS Covid Pass voluntarily.
Besides, the legal mandate to wear face masks will go away from next week.
Making a statement to the House of Commons on Covid-19, he said that infection levels are falling in England mainly because of the country's "extraordinary booster campaign".
He noted more than 36 million Covid-19 booster jabs had been delivered, with over 90 percent of over-60s now given a third dose.
"Our scientists believe it is likely that the Omicron wave has now peaked nationally," Johnson added, while cautioning "the pandemic is not over".
"I encourage everyone across the country to continue with all the cautious behaviours that we know help to keep each everybody safe."
Britain on Tuesday (January 4) faced warnings of an impending hospital crisis due to staff shortages caused by a wave of Omicron infections, as the country
returned to work after Christmas.
However, Britain's vaccine minister said hospitalised Covid-19 patients were showing less severe symptoms than before, adding that there was no need for further
restrictions at this stage.
Prime minister Boris Johnson resisted imposing stringent lockdown measures in England ahead of New Year as Omicron fuelled a spike in cases to record highs.
While hospitalisations are rising they have not tracked the trajectory of daily cases, possibly reflecting the impact of vaccines and booster shots, the likely lower severity of Omicron and the time lag in people going into hospital.
"At the moment, if you look at the people who have been hospitalised, they are going in with less severe conditions than before," minister for Vaccines and Public Health Maggie Throup told Sky News, adding that the "Plan B" Johnson brought in in December was working.
"The numbers that are in hospital beds is about half what it was a year ago - and that just shows the power of the vaccine."
Britain on Monday (January 10) put the biggest private health companies on high alert to deliver crucial treatments such as cancer surgery should Omicron
overwhelm National Health Service hospitals in England.
The United Kingdom's death toll from the Covid-19 pandemic stands at 150,154, the world's seventh worst official Covid toll after the United States, Brazil, India, Russia, Mexico and Peru.
Prime minister Boris Johnson has bet on refraining from lockdowns to deal with the Omicron variant which in recent weeks has swept across the UK, albeit with death
rates significantly lower than previous waves.
In a sign of just how stretched the NHS could become, health secretary Sajid Javid ordered England's NHS to strike a three-month deal with private health companies to allow patients to get treatments such as cancer surgery outside.
"Millions of patients have already got their tests and treatment quicker thanks to our existing deal with independent providers," said David Sloman, NHS England chief operating officer and Covid incident director.
Global pharmaceutical and biotechnology company AstraZeneca has signed an agreement with Scorpion Therapeutics to discover, develop and commercialize precision medicines against cancer proteins.
The collaboration, announced today (January 13), will focus on a class of proteins called transcription factors, which can regulate important cellular processes including cell growth and survival.
Many transcription factors have been identified earlier, but were considered 'undruggable' using conventional drug discovery approaches, the company said in a
statement.
Susan Galbraith, executive vice president, Oncology R&D, AstraZeneca, said: "Unlocking potentially transformative biology is pivotal for delivering the next wave of
cancer treatments.
"Scorpion's innovative platform is a strong strategic fit as we explore a range of new modalities across our broad drug discovery toolbox with promise to disrupt the activity of these highly-validated cancer targets."
NHS cancer check has set a new record, despite pressures on hospitals due to Covid-19, the number of people being treated for the cancer remained higher than
before the pandemic, revealed NHS.
Over the last 12 months almost three million people were referred for cancer checks which is up by over a tenth on the 2.4 million people referred before the
pandemic.
"Even at the peak of the Omicron wave, referrals for suspected cancer were at 116 per cent of pre-pandemic levels with around 11,000 people getting checked every
day over the last year," said NHS.
In order to meet increasing demand for cancer checks, NHS services across the country are expanding their diagnostic capabilities through one stop shops for tests,
mobile clinics and cancer symptom hotlines, ensuring people are diagnosed and treated as early as possible to give them a much better chance of beating the disease.
More than 30,000 people every month are being invited for lung cancer checks through NHS mobile trucks visiting at risk communities across the country, as part of
the biggest programme to improve early lung cancer diagnosis in health service history.
The routine, twice-weekly asymptomatic Covid-19 testing by pharmacy staff can be paused from the end of August.
The health regulator announced that regular asymptomatic testing for Covid-19 will be paused in all remaining health and care settings from 31 August 2022.
Currently all pharmacy staff test twice-weekly for Covid-19, using a self-administered Lateral Flow Device (LFD) test at home.
"Prevalence of Covid-19 in the community has fallen and remains at a comparatively low level as we emerge from the current Omicron wave. This means that the
likelihood that individuals entering healthcare settings are infectious has also reduced and the relative risk of onward transmission into these settings is lower."
All children aged five to 11 in England will be offered a Covid-19 vaccine, the government said on Wednesday (February 16) - following similar announcements
in the rest of the UK.
The move, coming nearly two months after British regulators approved Pfizer and BioNTech's shot for use among the age group, sees Britain following the lead of the
United States, the European Union and other countries.
It has only been vaccinating at-risk under-12s and those who live with immuno-suppressed people, using a lower-dose formulation of the jab that was found to be "safe
and effective".
However, health secretary Sajid Javid - who has responsibility for England only - said he had now accepted guidance from the Joint Committee on Vaccination and
Immunisation, which advises UK health departments, to expand the rollout.
"The NHS will prepare to extend this non-urgent offer to all children during April so parents can, if they want, take up the offer to increase protection against
potential future waves of Covid-19 as we learn to live with this virus," he said in a statement.
DE Group, one of the UK's leading independent pharmaceutical wholesalers, has gone into administration.
Pharmacy Business has learnt that the group was put into administration on Monday (May 9), putting hundreds of jobs at risk and stoking fears of a "sudden shock"
to pharmaceutical supply chain.
A community pharmacy contractor who has done business with the wholesaler for over 20 years told Pharmacy Business: "I fear for the worst. I don't think there will
be enough supply of medicines to cope up with a surge at such a short notice."
Bharat Shah, founder and CEO of Sigma Pharmaceuticals, another leading short-line wholesaler, said the news will send shock-waves and have "a massive impact on the
market" because DE Group enjoyed a "substantial coverage and market share" in the independent pharmacy sector.
"It won't be easy for anyone to take on the extra volume as it could jeopardise their own business," he said, adding that Sigma was actively looking into expanding its own operations in the foreseeable future.